Cough-Cold and Flu

STOCKHOLM -- Moberg Pharma has signed an agreement to acquire U.S. OTC brands New Skin, Fiber Choice and PediaCare from Prestige Brands, Inc.

The purchase price is $40 million and the acquired brands will be sold through Moberg’s current OTC channel in the U.S, primarily in drugstores such as CVS, Walgreens and Rite Aid and in mass retailers such as Walmart and Target.

ATLANTA - WellCare of Georgia, a subsidiary of WellCare Health Plans, enhanced its Medicaid benefits Thursday by adding new incentives to its healthy rewards program and increasing its over-the-counter and vision program benefits.

MERIDEN, Conn. - Protein Sciences announced Thursday that FDA has extended the shelf life for Flublok, its seasonal influenza vaccine, to nine months from the date of manufacture. That increases the previous shelf life by three months.  The longer shelf life will make it easier for healthcare providers and pharmacies to stock Flublok and vaccinate people throughout the influenza season, which in some years can last as long as April or May.

ATLANTA - The Center for Disease Control and Prevention's  Advisory Committee on Immunization Practices on Wednesday voted that live attenuated influenza vaccine, also known as the “nasal spray” flu vaccine, should not be used during the 2016-2017 flu season.

ACIP continues to recommend annual flu vaccination, with either the inactivated influenza vaccine or recombinant influenza vaccine, for everyone 6 months and older.

WAUKESHA, Wis. – Hamacher Resource Group will conduct a continuing education session titled“Becoming a Community Wellness Destination” at the McKesson ideaShare 2016 conference next week, the company announced Thursday.

BOSTON – BV Investment Partners on Thursday announced the sale of ECRM, an integrated services, software and data provider serving consumer product manufacturers and retailers, to Snow Phipps Group.

Financial terms were not disclosed.

PHILADELPHIA - The availability of influenza vaccinations at the neighborhood pharmacy has boosted vaccination rates among millennials, according to research recently published in the American Journal of Public Health.

The authors found that increased adoption rates followed states allowing pharmacists to administer the vaccine.